Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Sacituzumab Tirumotecan for Endometrial Cancer
Recruiting2 awardsPhase 3
Montréal, Quebec
This trial compares MK-2870 to Treatment of Physician's Choice (TPC) to see if MK-2870 is better at progression-free survival & overall survival.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service